Aspira Women's Health Inc. · OTC:AWHL
Aspira Women's Health — Vermillion — Q4 2019 Earnings Presentation
7 slides from Aspira Women's Health's earnings presentation, Mar 26, 2020
Slide 1: Vermillion Q4 2019 Earnings Highlights
Vermillion Q4 2019 Earnings Highlights
Slide 2: Forward-looking statements
This presentation contains forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. Words such as “may,” “expects,” “intends,” “anticipates,” “believes,” “estimates,” “plans,” “seeks,” “could,” “should,” “continue,” “will,” “potential,” “projects” and similar e
Slide 3: Vermillion, Inc. Innovation Pipeline
Vermillion, Inc. Innovation Pipeline All release dates based on management estimates
Slide 4: Patient Lifecycle with OVA Technology
Patient Lifecycle with OVA Technology – solving diagnostic dilemmas from puberty to cure
Slide 5: Q4 2019 YOY Highlights
Q4 2019 YOY Highlights Q4FY19 vs Q4FY18 Product Volume Increased 93% 3854 units Q4 FY19 vs 1996 units Q4 FY18 Product Revenue Increased 62% $1.3M in Q4 FY19 vs $0.79M in Q4 FY18 Total Customers Increased 83% New Customers Increased 61% Other Key Metrics Total ordering physicians Q4 YOY – increase of
Slide 6: OVA1 Weekly Volumes
OVA1 Weekly Volumes Weekly Volume 2019 Note: While we did continue to hit an annualized run rate of 16 to 17k, it was slightly less than we forecasted as the holiday calendar impacted patient visits . W e believe many patients took an entire week off and did not schedule doctor appointments.
Slide 7: Vermillion Our Mission
Vermillion Our Mission Enable Early Ovarian Cancer Detection for All Ages and Ethnicities